- As pharma descends on China for deals, BIOSECURE Act raises intellectual property riskWhen signing a biotech licensing deal in China, experts say that pharma’s patent attorneys need to understand the geopolitical risk of the BIOSECURE Act.BioSpace · 4h ago↗ source
- STAT+: HIV resurgence is feared as global funding to combat the disease falls 18%The world risks a resurgence of the HIV epidemic after international financing to combat the disease suffered a “profound shock” last year, according to a new report from UNAIDS.STAT · 12h ago↗ source
- STAT+: Pharma’s drug spending deflectionJob lock, surging prescription drug costs, No Surprises Act update, and more from STAT's Health Care Inc.